National Cancer Institute HIV/AIDS Cancer Programs
description
Transcript of National Cancer Institute HIV/AIDS Cancer Programs
![Page 1: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/1.jpg)
National Cancer Institute HIV/AIDS Cancer
Programs
Mostafa Nokta, MD Ph.D.
Chief, AIDS Cancer Clinical Program
Office of HIV and AIDS Malignancy
National Cancer Institute
Nati
onal
Can
cer I
nstit
ute
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
![Page 2: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/2.jpg)
Cancers in HIV Disease
AIDS-Defining Virus Kaposi’s Sarcoma HHV-8 Non-Hodgkin’s Lymphoma EBV, HHV-8
(systemic and CNS) Invasive Cervical Carcinoma HPVNon-AIDS Defining Anal Cancer HPV Hodgkin’s Disease EBV Leiomyosarcoma (pediatric) EBV Squamous Conjunctival Carcinoma HPV (?) Hepatoma HBV, HCV
![Page 3: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/3.jpg)
![Page 4: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/4.jpg)
Change in Incidence of Cancers in HIV in the cART Era in USA
Kaposi’s sarcoma CNS Lymphoma Lymphoma (NHL and CNS) Lymphoma (HD) Anal Cancer Lung Cancer Cervical Cancer Breast Hepatoma
Patel P et al, Ann Intern Med 2008;148:728-736
![Page 5: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/5.jpg)
Dual Burden of KSHV and HIV Infection in Africa Fuel an Epidemic of Kaposi’s Sarcoma
HIV KS KS Incidence
![Page 6: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/6.jpg)
Office of HIV & AIDS Malignancy
AIDS Malignancy Program
AIDS Cancer Clinical Program
• CFAR• WIHS• MACS• IeDEA• AITRP
• AIDS Malignancy Consortium (AMC)• ACSR•INCTR•ACTG• SPOREs (Lung, Lymphoma, Head & Neck)
![Page 7: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/7.jpg)
AIDS Malignancy Clinical Trials Consortium
![Page 8: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/8.jpg)
AIDS Malignancy Consortium (AMC)
Evaluate clinical interventions for the treatment and prevention of malignancies in people with HIV
Investigate the biology of these malignancies in the context of clinical trials
Conduct Phase I, II and III clinical trials Address issues of international importance in HIV
associated malignancies Contribute specimens and clinical data to the
ACSR
![Page 9: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/9.jpg)
AMC International Objectives
Assist with capacity building in developing nations for international HIV-related cancers
Develop AMC-sponsored and co-sponsored collaborative studies with emphasis on trials that:
- Employ hypothesis-driven, scientifically sound, locally relevant and feasible therapies
- Address important pathogenesis-based questions - Utilize the unique scientific expertise of the AMC
![Page 10: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/10.jpg)
Current International Protocols
Protocol Project Site(s) CommentAMC 049 Sunitinib in AIDS KS Uganda, Kenya Active
AMC 050 KSHV viral transcription Brazil Active
AMC 054 Quadrivalent HPV vaccine IndiaLocal Gov
Review
AMC 055 Indinavir endemic KS Uganda Active
AMC 056 Indinavir endemic KS ZimbabweCTEP/IRB
review
AMC/ACTG 5263/5264
Treatment of early and late KS
Several sites in Africa
In development
AMCOral chemo and Modified
CHOP for AIDS NHLTBD In development
![Page 11: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/11.jpg)
AMC International Sites
Uganda, Kampala Kenya, Nairobi Zimbabwe, Harare India, Mumbai, Chennai, Tamil Nadu Brazil, Sao Paulo Australia, Darling Hurst, NSW Dr. Mostafa Nokta, [email protected]
Dr. Ron Mitsuyasu, [email protected]
![Page 12: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/12.jpg)
![Page 13: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/13.jpg)
ACSR Mission
To provide high-quality HIV-associated malignancy specimens to qualified
investigators at little or no cost
![Page 14: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/14.jpg)
ACSR Specimens• > 500,000 specimens and growing• Twenty different diagnosis codes (CA and controls)• Types of specimens
– Frozen tissues – PBMCs– Plasma– Body fluids (e.g., saliva, urine, CSF) – Formalin – fixed tissues
• Associated Clinical Data
![Page 15: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/15.jpg)
West Coast CoastMid-Mid-RegionRegion
East East CoastCoast
ACSR Representation
![Page 16: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/16.jpg)
“Collections” within the ACSR
• TMAs (NHL, KS)
• AMC studies
• WIHS Study
• HIV multi-site autopsies
• SF Gay men’s KS epidemiology study (Martin et al.)
• International specimens– Thailand HIV+ Plasma (vaccine study)
– Rwandan women (WIHS)
– Ugandan KS and natural history (Martin et. Al.)
![Page 17: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/17.jpg)
ACS “Resource”
• Searchable on the Web – http://acsr.ucsf.edu
• Facilitate collaborations with investigators and specimen sources
• Procurement of requested specimens if not in the ACSR collection
Dr. Mike McGrath [email protected]
![Page 18: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/18.jpg)
Comprehensive Cancer Centers
Cancer Centers
Planning Centers
Cancer Centers
Dr. Hasnaa [email protected]
![Page 19: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/19.jpg)
International Network for Cancer Treatment and Research
• The INCTR is a non for profit, non governmental organization dedicated to helping to build capacity for cancer treatment and research in countries with limited resources.
• Capacity building, Palliative care and educational programs• Disease interests: NH lymphoma, cervical cancer
Dr. Ian Magrath, PIhttp://www.inctr.org/
![Page 20: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/20.jpg)
NCI/OHAM Cofunded Programs
MACS, Multicenter AIDS Cohort Study WIHS, The Women's Interagency HIV Study CFARs, Centers for AIDS Research IeDEA, International Epidemiologic Databases
to Evaluate AIDS AITRP, AIDS International Training
and Research Program
![Page 22: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/22.jpg)
• Australia• Cambodia• India• Indonesia• Japan• China• Malaysia• Singapore• Thailand
Region 5: Australia, India, Pakistan, Asia
• Burundi• Cameroon• Central African Republic• Congo, Dem. Rep. of (Zaire)• Congo, Republic of• Rwanda
Region 8: Central Africa
• Botswana• Malawi• Mozambique• South Africa• Zambia• Zimbabwe
Region 8: Southern Africa
• Kenya• Tanzania• Uganda
Region 8: East Africa
• Argentina• Brazil• Chile• Haiti• Honduras• Peru•Mexico
Region 2: Latin America & Caribbean
Region 1: North America Canada• United States
Region 8: West Africa
• Mali• Nigeria• Senegal
• Benin• Cote d'Ivoire• Gambia
NCI NICHD
![Page 23: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/23.jpg)
Funding Opportunities for AIDS Malignancies
Research on Malignancies in the Context of HIV/AIDS (R01 and R21)
http://grants.nih.gov/grants/guide/pa-files/PA-07-454.html and
http://grants.nih.gov/grants/guide/pa-files/PA-07-455.html
Research on Non-AIDS Defining Cancers & AIDS-associated Malignancies
Tentative
![Page 24: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/24.jpg)
Hepatocellular Carcinoma
PA-08-243 R01 (Research Grants)http://grants.nih.gov/grants/guide/pa-files/PA-08-243.html
PA-08-244 R21 (Exploratory/Developmental Grants) http://grants.nih.gov/grants/guide/pa-files/PA-08-244.html
• PAR-08-245 P01 (Program Project Grants) http://grants.nih.gov/grants/guide/pa-files/PAR-08-245.html
![Page 25: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/25.jpg)
Capacity Building
RFA: Strengthening Capacity for HIV-Associated Malignancies in Africa
PI from a US institution and an African Institution
Will support training in all disciplines from basic to clinical research to lay the foundation for the African/US investigators to seek future independent research grants on AIDS-related cancers
![Page 26: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/26.jpg)
International Conference on Malignancies in AIDS & Other Acquired Immunodeficiencies
12th ICMOI, April 26 & 27, 2010 Bethesda, MD, USA
For more Information: Contact: Dr. Rebecca Huppi, [email protected] Ms. Denise Jenkins, [email protected]
![Page 27: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/27.jpg)
HIV Cancer Resources
Office of HIV and AIDS Malignancy
(OHAM) WEB Site
http://oham.cancer.gov/
![Page 28: National Cancer Institute HIV/AIDS Cancer Programs](https://reader035.fdocuments.us/reader035/viewer/2022062423/56814764550346895db4a13f/html5/thumbnails/28.jpg)
Enhance Collaborations